New Zealand biggest dairy firm, Fonterra, recently collaborated with International Osteoporosis Foundation (IOF) to fund...
Singapore: Australia firm focused on sleep disorder, ResMed, has completed the previously announced acquisition of China...
Singapore: Australian shareholders are being given the opportunity to buy into a highly promising biotech with a vaccine...
Singapore: If reports are to be believed, Australia's defence force has enlisted a new e-health system. The multi-millio...
Elastatherapy is a technology that has the potential to reverse ageing process and enable skin regeneration. The technol...
Singapore: Starpharma Holdings announced the positive results of its exploratory phase II study of VivaGel for the preve...
Singapore: GVK BIO has announced an extended collaboration with the Australia-based clinical stage biopharmaceutical com...
Singapore: Researchers from the University of Queensland in Australia have identified that existing drugs could be repur...
Singapore: The registrations are open for the Indo-Australian international conference which will host reputed scientist...
Singapore: Australia's Anteo Diagnostics has inked a partnership deal with Sigma-Aldrich, a leading supplier of lifescie...
Singapore: Phosphagenics has announced that it has completed enrolment for a phase II trial of an acne treatment candida...
Singapore: Australian immuno-oncology company, Minomic International, is set to launch the first human study of its nove...
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Jap...
Singapore: A new drug discovered by researchers' from the University of South Australia and the Third Military Medical U...
Singapore: Though vaccination is considered the most important procedure for healthcare and disease management, it is n...
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has partnered with European...
Singapore: Australia based Prana Biotechnology has recieved positive opinion from European Medicines Agency's Committee ...
Singapore: Phylogica has engaged Griffin Securities, a specialty investment bank located in New York City, to conduct a ...
